VCANBIO CELL & GENE ENGINEERING financial statements, including revenue, expenses, profit, and loss

The total revenue of 600645 for the last quarter is 398.39 M CNY, and it's 0.12% lower compared to the previous quarter. The net income of Q3 24 is 48.33 M CNY.